Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics → Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
SOP Plug-and-play starting point AI & Automation

SOP: Governance of AI-Assisted Regulatory and CMC Content

A plug-and-play standard operating procedure for governing AI-assisted regulatory and CMC content: use classification, system control, source grounding and citation, human authorship, records, change control, and monitoring, with a filled specimen and the regulations it satisfies.

Document type: SOP

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use SOP for governing AI-assisted regulatory affairs and CMC content, so the output is accurate, traceable, and ready to put in front of a health authority. A regulatory submission is a representation to a regulator and a labeling statement is a patient-safety document; the accuracy and accountability bar does not move because AI helped produce the content. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control. A filled specimen follows. Verify each cited regulation against the current source before you rely on it.

Document control header

FieldEntry
Document titleGovernance of AI-Assisted Regulatory and CMC Content
Document number<<FILL: SOP-ID, e.g. SOP-RA-018>>
Version<<FILL: version>>
Effective date<<FILL>>
Supersedes<<FILL: prior version or "New">>
Document owner<<FILL: role, e.g. Head of Regulatory Affairs>>
Applies to<<FILL: functions / content types in scope>>

1. Purpose

This procedure defines how <<FILL: COMPANY NAME>> uses AI to assist the production of regulatory and CMC content while keeping the accountability, accuracy, and traceability of that content exactly where they sit for any submitted content: with named humans and a documented record.

2. Scope

This procedure applies to any use of AI to draft, summarize, assemble, check, or research regulatory and CMC content, including submission modules, responses to agency questions, labeling comparisons, and regulatory intelligence. It applies whether the AI is a vendor service or an internal capability. It does not authorize any use in which AI-generated content becomes filed content without a qualified human authoring and owning it.

3. Responsibilities

RoleResponsibility
Regulatory Affairs leadOwns the use classification and the accountability map; approves the AI uses in scope.
Named author (regulatory / medical writer)Authors and owns AI-assisted content, verifies every claim against source, and applies regulatory judgment.
QA / Regulatory approverApproves filed content through the controlled workflow; owns this procedure and the monitoring.
IT / Data ScienceSelects, validates, and version-controls the AI capability; pins the model where allowed.
Document ControlRetains the records of AI involvement and the source-to-claim traceability.
Information securityGoverns what data may be fed to the AI service and monitors access.

4. Definitions

  • Assistive draft: AI-generated content that a qualified human verifies, corrects, and owns before it becomes regulatory output.
  • Retrieval grounding: configuring the AI to draft from specific provided source documents and cite them, rather than relying on its general training.
  • Confabulation (hallucination): a fluent, confident, but wrong specific produced by a generative model, for example a misstated specification limit or an invented citation.
  • Direct-to-record: AI output entering a controlled record without human authoring. Not an acceptable pattern for regulatory content.

5. Procedure

5.1 Classify the use and set accountability

  1. For each AI use, write one sentence naming the output, what it feeds, and the named human who owns the result.
  2. Assign a tier: internal intelligence, assistive draft, or consistency/conformance check. No use may sit in the direct-to-record tier.
  3. Record the classification and the accountable role.

5.2 Pin and control the AI system

  1. Where the AI is a vendor service, pin the model version where the vendor allows and capture the vendor’s model-change behavior in the software supplier assessment.
  2. Treat the part you control, the prompts, the retrieval configuration, the guardrails, and the output handling, as the configured artifact you validate and version.
  3. Validate to the intended use and risk tier, not to a generic claim that the AI works.

5.3 Ground every claim in a verifiable source

  1. Configure retrieval grounding so the model drafts from the specific provided source documents and cites the source for each statement.
  2. Verify every regulatory citation against the primary source; do not let the model assert a guidance number, regulation identifier, or date that has not been checked.
  3. Treat numbers as high-risk tokens: specification limits, results, dates, identifiers, and statistics are verified against source individually, not skimmed in context.

5.4 Make human authorship explicit

  1. Name the author who takes ownership of the AI-assisted content; the author is accountable, not the AI.
  2. The author performs a substantive review: claim-by-claim verification against source, confirmation of high-risk specifics, and regulatory judgment on framing.
  3. Record the authoring and approval in the controlled document workflow under document control, with the Part 11 electronic signature.
  4. Train authors and reviewers on the AI’s known failure modes so they review with the right suspicion.

5.5 Preserve traceability and records

  1. Retain, for content that becomes regulatory output, a record of the AI’s involvement scaled to risk: which system and version, what sources it was grounded in, and the human authoring and review that followed.
  2. Keep the source-to-claim traceability intact through the AI step.
  3. Keep drafts and source links in the controlled document system, not in an ungoverned AI tool’s chat history.

5.6 Govern change

  1. For labeling and filing changes, the AI assists the comparison and drafting only; the change runs through controlled change control with qualified approval. A labeling change never reaches a label on AI output alone.
  2. For the AI system, classify anticipated changes in advance. A vendor base-model update is an uninitiated change: re-run a known-content check and hold reliance until it passes. A prompt or retrieval-source change triggers a re-verification on representative content.

5.7 Monitor the assisted process

  1. Track the rate and nature of corrections reviewers make to AI drafts; a rising error rate signals a behavior change, a near-zero edit rate signals slack review.
  2. Periodically audit a sample of AI-assisted content against source.
  3. Investigate any AI-introduced error that reached a late stage or a submission as a quality event with root cause and corrective action, and feed findings back into prompts, guardrails, and training.

6. Acceptance criteria

  • Every AI use has a written classification and a named accountable role; none is direct-to-record.
  • For any AI-assisted output you can state which system and version produced it and what it was grounded in.
  • Every factual claim traces to a verified source; every regulatory citation is checked against the primary reference.
  • Every filed AI-assisted output has a named human author, a recorded substantive review, and controlled approval.
  • Labeling and filing changes go through controlled change management regardless of AI assistance.
  • Correction rates are tracked, a periodic audit runs, and AI-error escapes are investigated.

7. References

21 CFR Part 11 (electronic records and signatures); the Federal Food, Drug, and Cosmetic Act for the standard applying to submitted content. EU GMP Annex 11 (Computerised Systems); the draft Annex 22 on artificial intelligence (7 July 2025, not in force), which as drafted limits generative AI to non-critical uses with documented human oversight. FDA draft guidance, “Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products” (January 2025, draft), for the risk-based credibility approach. ICH Q9(R1), Quality Risk Management.

Confirm the current version and status of each reference before issue; the AI guidances are drafts.

8. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL: date>><<FILL: author>>Initial issue.

9. Approvals

RoleNameSignatureDate
Author<<FILL>>
Reviewer (Regulatory)<<FILL>>
Approver (QA)<<FILL>>

Filled specimen

The following shows the use classification for one example use, so you can see the expected detail. The values are illustrative; replace them with your own.

FieldEntry
AI useDraft first-pass nonclinical written summaries from completed study reports
TierAssistive draft
One-sentence classificationThe AI produces a first-pass draft of the nonclinical written summary from the provided study reports; the lead regulatory writer verifies every claim against the source reports, edits, and owns the final section; QA approves through the document workflow.
Accountable roleLead regulatory writer for the program
System and versionVendor language-model service, version pinned; grounded by retrieval in the program’s study reports
Grounding and citationGuardrail requires each statement to cite its source report and page
Records retainedControlled document record notes the AI system, version, sources, and the human authoring and review

In this example the classification sentence makes the AI an assist and the writer the owner, the grounding forces a checkable citation on every statement, and the record captures how the content was produced. An inspector or sponsor auditor can follow the section from source study report to filed claim with a named human accountable at each step.

Common inspection findings this SOP prevents

  • An unverifiable claim in submitted content, a fluent but wrong specific no one checked.
  • A fabricated or mis-numbered citation the model produced and no one verified.
  • No record of how AI-assisted content was produced, so the process cannot be reconstructed when questioned.
  • Regulatory drafts living in a consumer AI tool’s chat history, outside any controlled system.
  • Rubber-stamp authorship revealed by a near-zero edit rate.
  • A vendor model change that passed unnoticed, so the validated behavior lapsed silently.

How to adapt this SOP

  1. List your actual AI uses and classify each; delete tiers you do not use and record why.
  2. Point the cross-references to your real supplier-assessment, document-control, and change-control procedures.
  3. Set the monitoring cadence and the audit sample size to values you will actually run.
  4. Keep the AI guidances flagged as drafts until they are finalized, and confirm their status before you cite them.
  5. Confirm every regulation in section 7 against the current published version before issue.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.